/
Pharmaceutical preparations company · NV · FY ends Dec · Revenue $18M · -862.69% margin · -$131M FCF
The business is unprofitable at the operating level (-961.33% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 29.5% YoY with margins expanding 393.0pp.
Negative free cash flow of -$103M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$18M
▲ +29.5% YoY
Net Income (TTM)
-$147M
▲ +4.6% YoY
Op. Margin
-862.69%
▲ +393.0pp YoY
ROIC
-54.60%
▲ +31.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$131M
▼ -69.1% YoY
Op. Cash Flow (TTM)
-$126M
▼ -63.9% YoY
Net Debt
-$184M
Net Cash Position
Cash & Equiv.
$185M
Continue Research